| 1st May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 30th Apr 2025 7:05 am |
RNS |
Transaction in Own Shares |
| 30th Apr 2025 7:00 am |
RNS |
1st Quarter Results |
| 29th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 28th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 25th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 24th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 23rd Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 22nd Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 17th Apr 2025 4:13 pm |
RNS |
Blenrep licensed by UK MHRA |
| 17th Apr 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 17th Apr 2025 7:10 am |
RNS |
Arexvy now ACIP recommended for 50-59 at risk |
| 17th Apr 2025 7:05 am |
RNS |
GSK 5-in-1 meningitis vaccine recommended in US |
| 17th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 16th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 15th Apr 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 15th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 14th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 11th Apr 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 11th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 10th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 9th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 8th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 7th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 4th Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 3rd Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 2nd Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 1st Apr 2025 3:30 pm |
RNS |
Total Voting Rights |
| 1st Apr 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 31st Mar 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 28th Mar 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 28th Mar 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 27th Mar 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 26th Mar 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 25th Mar 2025 4:34 pm |
RNS |
GSK uUTI treatment approved by US FDA |
| 25th Mar 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 24th Mar 2025 4:10 pm |
RNS |
Notice of AGM |
| 24th Mar 2025 7:05 am |
RNS |
EMA Filing acceptance for Nucala COPD |
| 24th Mar 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 21st Mar 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
